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Introduction {#sec1}
============

Human pluripotent stem cells (hPSCs) integrate multiple signals to determine cell fate. These signals include soluble factors, such as growth factors and small molecules, neighboring cells, and insoluble cues, such as the extracellular matrix composition and rigidity ([@bib18], [@bib25], [@bib35]). Matrix rigidity influences the cell fate of adult stem cells ([@bib10], [@bib11]), and the elasticity (or rigidity) of an hPSC\'s microenvironment can potently signal self-renewal or differentiation ([@bib26], [@bib27], [@bib32]). We previously showed that when hPSCs are cultured in microenvironments with elasticities comparable with human brain tissue, they efficiently differentiate to neurons---without soluble neurogenic factors ([@bib27]). The transcriptional coactivator Yes-associated protein (YAP) can mediate responses to substrate stiffness in mesenchymal stem cells ([@bib10]) and hPSCs. When hPSCs are cultured on a rigid surface, such as polystyrene or glass, YAP localizes to the nucleus and hPSCs self-renew ([@bib26]). In contrast, when cells are cultured on soft substrates or with small-molecule inhibitors of F-actin polymerization, YAP translocates out of the nucleus and the cells differentiate to neurons ([@bib27]). Knockdown of YAP in cells on rigid surfaces induces neuronal differentiation, phenocopying cell growth on soft surfaces or in the presence of compounds that disrupt F-actin polymerization.

Beyond mechanotransduction, YAP participates in an array of cellular processes including Hippo signaling, tissue homeostasis, cancer stem cell reprogramming, and growth factor signaling ([@bib31]). The regulation of YAP has been characterized in the contexts above but not in hPSC fate. This latter context is relevant as YAP helps maintain the mammalian stem cell pluripotency. In mouse embryonic stem cells (ESCs), knockdown of YAP led to the loss of pluripotency factors OCT4 and SOX2 and consequent differentiation ([@bib20]). In hPSCs, YAP/TAZ-SMAD2/3 complexes engage with TEA domain (TEAD) transcription factors and OCT4 ([@bib4]). YAP also helps promote the self-renewal of neural stem cells (NSCs), although how it does so is not well understood. In the developing chick neural tube, YAP gain of function significantly expanded the neural progenitor pool in a TEAD-dependent manner ([@bib7]). Repression of YAP/TEAD target genes led to cell-cycle exit and premature neuronal differentiation. Similar results were observed for NSCs in the mouse embryonic brain ([@bib16]). YAP induction also can reprogram terminally differentiated neurons into NSCs ([@bib30]). Transient YAP expression was sufficient to induce NSCs and promote self-renewal.

We sought to understand better the molecular mechanisms regulating YAP subcellular localization in hPSCs during self-renewal and differentiation. Prior studies have characterized YAP interactors in immortalized cell lines ([@bib8], [@bib19], [@bib33]), but how YAP interactions change during differentiation is unclear. We employed CRISPR/Cas9 to generate an hPSC line in which YAP is tagged, thus facilitating affinity purification of endogenous-level YAP complexes for analysis. This strategy uncovered proteins that interact with YAP during self-renewal and differentiation and pointed to angiomotin (AMOT) as a critical regulator of YAP localization during neural differentiation.

Results {#sec2}
=======

CRISPR/Cas9 Generation of an hPSC Line with Tagged YAP {#sec2.1}
------------------------------------------------------

We employed CRISPR/Cas9 and took advantage of homology-directed repair to engineer the H9 human ESC line to produce a C-terminal 3xFLAG-tagged YAP ([Figure 1](#fig1){ref-type="fig"}A). After puromycin selection and clone screening, we isolated a clone in which the introduced tag was present in both alleles ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In this YAP-FLAG cell line, the FLAG tag was universally expressed and entirely coincident with YAP staining ([Figure 1](#fig1){ref-type="fig"}B). As expected, this engineered cell line expressed the pluripotency markers NANOG and OCT4 ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The fusion protein also retained proper localization in response to mechanical cues: YAP-FLAG was present in the nucleus on rigid surfaces; the fusion protein was detected in the cytoplasm on soft surfaces ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Treatment with latrunculin A (lat-A), an F-actin polymerization inhibitor that elicits a cellular response akin to that caused by culture on soft surfaces, also resulted in YAP-FLAG detection in the cytoplasm ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The YAP-FLAG cell line allowed for highly specific affinity purification of YAP with anti-FLAG magnetic beads ([Figure 1](#fig1){ref-type="fig"}C). Moreover, YAP copurified with well-characterized binding partners, including the TEAD transcription factors and 14-3-3 adaptor proteins ([Figure 1](#fig1){ref-type="fig"}C). Therefore, application of CRISPR/Cas9 afforded an hPSC line in which a tagged YAP is produced from its endogenous genomic locus; this cell line enables the affinity purification of endogenous-level YAP complexes. Together, these results indicated that the YAP-FLAG cell line could reveal relevant YAP interactors.Figure 1CRISPR/Cas9-Mediated Editing Enables Generation of an hPSC Line in which FLAG-Tagged YAP Is Produced from Its Native Chromosomal Locus(A) Scheme for the generation of the 3xFLAG-tagged YAP hPSC line (H9) using CRISPR/Cas9 and homology-directed repair.(B) YAP subcellular localization in H9 YAP-FLAG cell line. Scale bar, 50 μm.(C) Top: immunoblots from FLAG coimmunoprecipitation (IP) from H9 wild-type (WT) and H9 YAP-FLAG cell line lysates. Bottom: IP input.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Enhancement of the YAP-AMOT Interaction during Neural Differentiation {#sec2.2}
---------------------------------------------------------------------

The YAP-FLAG cell line was used for affinity purification-mass spectrometry (AP-MS) to characterize the YAP interactors within hPSCs ([Figure 2](#fig2){ref-type="fig"}A). As expected, immunoprecipitation from undifferentiated H9 cell lysates with anti-FLAG magnetic beads afforded YAP as the protein most highly enriched in YAP-FLAG cells relative to wild-type cells ([Table S1](#mmc1){ref-type="supplementary-material"}). Previously characterized YAP binding partners (e.g., PTPN14, TEAD1--4, and 14-3-3 proteins) ([@bib37]) were also enriched. We additionally detected several novel interactors (e.g., ARID3B and SALL4) ([Figure 2](#fig2){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}) and noted an absence of enrichment for the Hippo kinases LATS1/2.Figure 2AMOT Interaction with YAP Increases during Neural Differentiation(A) Diagram of affinity purification-mass spectrometry for YAP-FLAG. coIP, coimmunoprecipitation; LC-MS/MS, liquid chromatography-tandem mass spectrometry.(B) Graphic representations of the top proteins enriched in FLAG coIP from H9 YAP-FLAG cells. Edges denote previously characterized interactions. Node colors represent protein groupings as follows: yellow, bait (YAP-FLAG); red, junction proteins; blue, transcription factors; teal, DNA binding proteins; green, 14-3-3 proteins; purple, ubiquitin-proteasome pathway.(C) H9 YAP-FLAG cells differentiated to PAX6 and/or SOX2^+^ neural progenitor cells. Scale bar, 50 μm.(D) Top 5 protein interactions with YAP-FLAG that significantly increased or decreased during neural differentiation (H9 YAP-FLAG diff versus H9 YAP-FLAG undiff, H9 WT diff is control).See also [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

To determine those interactors that regulate YAP localization during neural differentiation, we examined which partners change as cells differentiate. YAP is expressed in NSCs but not in neurons, so we monitored cells for NSC markers in the early stages of neuronal differentiation ([@bib9]). After 6 days, the majority of the cells expressed PAX6 and/or SOX2, markers of NSC state ([Figure 2](#fig2){ref-type="fig"}C). We then used AP-MS to compare YAP\'s binding partners in differentiated and undifferentiated cells. During the differentiation, we found an increase among YAP\'s protein interaction network with cytoplasmic proteins (e.g., HSPA1A and UGDH), including with members of the ubiquitin-proteasome pathway (e.g., HUWE1 and UBA1) ([Figure 2](#fig2){ref-type="fig"}D and [Table S2](#mmc1){ref-type="supplementary-material"}). The increase in cytoplasmic interactions was accompanied by a decrease in YAP interaction with nuclear proteins (e.g., TMPO, ARID3B, and SALL4). The most significant increase among YAP\'s protein interaction network was with the tight junction (TJ) protein AMOT ([Figure 2](#fig2){ref-type="fig"}D and [Table S2](#mmc1){ref-type="supplementary-material"}). These results suggest that AMOT is a regulator of YAP during neural differentiation.

AMOT Upregulation and YAP Downregulation during Neural Differentiation {#sec2.3}
----------------------------------------------------------------------

The increase in YAP-AMOT complexes during differentiation prompted us to examine whether cellular concentrations of AMOT increase. AMOT levels are low in hPSCs but progressively escalate as cells differentiate to the NSC and neuronal states ([Figure 3](#fig3){ref-type="fig"}A). During neural differentiation we found an increase in interactions with YAP and proteins of the ubiquitin-proteasome pathway; therefore, we examined whether this pathway influences YAP levels. During neuronal differentiation, *YAP* mRNA levels did not change substantially, but YAP protein levels decreased significantly ([Figure S2](#mmc1){ref-type="supplementary-material"}A). When the proteasome was inhibited with MG-132 during neural differentiation, the levels of both YAP and AMOT were enhanced ([Figure 3](#fig3){ref-type="fig"}B). These data indicate that the proteasome can downregulate YAP.Figure 3AMOT Expression Increases while YAP Is Downregulated during Neuronal Differentiation(A) Protein levels of AMOT, neuronal marker β-tubulin III (TUJ1), and NSC marker PAX6 during neuronal differentiation from H9 cells. d, day.(B) Protein levels of YAP and AMOT following treatment for 1 h with DMSO or 1 μM MG-132 at day 6 of neural differentiation.(C) Protein levels of AMOT, AMOTL1, and AMOTL2 in undifferentiated H9 cells versus H9-derived NSCs.(D) Subcellular localization of AMOT, F-actin, and YAP in H9-derived NSCs. Filled arrows indicate colocalization. Scale bar, 50 μm. (also applies to E).(E) Expression of YAP and TUJ1 (left) or AMOT and TUJ1 (right) in Neurog2-T2A-GFP H9 cells, 12 h after induction. Filled arrows indicate GFP^+^ cells, and empty arrows cells with low or absent GFP expression.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We further explored the link between AMOT and YAP in neural differentiation. AMOT has two paralogs, angiomotin-like 1 and angiomotin-like 2 (AMOTL1 and AMOTL2). AMOTL1 and AMOTL2 are also expressed in H9-derived NSCs, albeit at lower levels than AMOT. AMOT was the protein that exhibited the most significant increase in expression in NSCs relative to undifferentiated cells ([Figure 3](#fig3){ref-type="fig"}C). In NSCs, AMOT colocalized with both F-actin and YAP at TJs ([Figures 3](#fig3){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}B). As expected due to its role in promoting NSC self-renewal, YAP was present in the nucleus of NSCs. To examine AMOT and YAP dynamics during neuronal differentiation, we generated a stable H9 cell line harboring an inducible system in which expression of *Neurog2* drives neuronal differentiation ([Figure S2](#mmc1){ref-type="supplementary-material"}C) ([@bib38]). At 12 h following doxycycline addition, cells with low levels of *Neurog2* induction remained undifferentiated. These cells produced low levels of AMOT, and YAP was robustly detected in the nuclei. In contrast, differentiated neuronal cells upregulated AMOT while YAP levels decreased ([Figures 3](#fig3){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}E, and S2F). Accordingly, expression of *CTGF*---a well-characterized YAP target gene ([@bib37]), including in hPSCs ([@bib27])---significantly decreased ([Figure S2](#mmc1){ref-type="supplementary-material"}E).

Our detection of AMOT upregulation during neuronal differentiation of hPSCs led us to hypothesize that a similar upregulation could occur during the differentiation of adult mammalian NSCs. One of the main sites of adult neurogenesis is in the subgranular zone (SGZ) of the dentate gyrus ([@bib12]). NSCs in the SGZ differentiate to intermediate neural progenitors, which migrate and eventually give rise to hippocampal granule neurons ([@bib36]). A subset of non-neuronal cells in the SGZ of the mouse dentate gyrus expressed YAP. In differentiated cells expressing the neuronal marker MAP2, we detected lower YAP levels and increased AMOT levels ([Figure S2](#mmc1){ref-type="supplementary-material"}F). The accumulated data indicate that AMOT expression increases as cells differentiate to NSCs and neurons, and YAP is excluded from nuclei and downregulated by the proteasome.

AMOT Regulates YAP Localization in hPSCs {#sec2.4}
----------------------------------------

During differentiation, increases in AMOT expression coincide with YAP nuclear exclusion; therefore, we examined AMOT\'s role in this process. AMOT has two main isoforms: p130, which contains binding sites for F-actin and YAP, and p80, which lacks these sites ([@bib39]). Forced expression of p130, but not p80, resulted in YAP nuclear exclusion ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). The low levels of cytoplasmic YAP prompted us to assess whether YAP undergoes proteasomal degradation upon forced expression of AMOT-p130. When we added the proteasome inhibitor MG-132, we detected an increase in YAP and AMOT colocalization in the cytoplasm ([Figure 4](#fig4){ref-type="fig"}B). Since F-actin depolymerization triggers YAP nuclear exclusion ([Figure S1](#mmc1){ref-type="supplementary-material"}B) and promotes neuronal differentiation ([@bib27]), we hypothesized that a reduction in F-actin would increase the AMOT-p130 interaction with YAP. Treatment with lat-A had no effect on YAP interactions with the p80 AMOT isoform, but we detected a time-dependent increase in the interaction of AMOT-p130 with YAP ([Figure 4](#fig4){ref-type="fig"}C).Figure 4AMOT-p130 Control of YAP Localization in Response to the Actin Cytoskeleton(A) Top panels: subcellular localization of YAP in AMOT130-T2A-GFP H9 cells (top) or AMOT80-T2A GFP H9 cells (bottom), 24 h after induction. Filled arrows indicate cells producing AMOT/GFP, and hollow arrows indicate cells that fail to produce AMOT/GFP. Bottom panel: quantification of YAP nuclear localization (n = 30 cells over three independent experiments); y axis is fluorescence intensity of YAP in the nucleus. Data are presented as mean ± SEM; ^∗∗∗^p \< 0.0001 by Student\'s t test.(B) Subcellular localization of YAP and AMOT following forced expression of AMOT-p130 and treatment with DMSO (left) or 1 h of 1 μM MG-132 (right).(C) Top: immunoblots of FLAG coimmunoprecipitation (IP) after 3 and 6 h of DMSO or 1 μM lat-A treatment. Bottom: IP input.(D) Subcellular localization of YAP (top) or F-actin staining (bottom) after treatment with DMSO (left), 6 h of 1 μM lat-A (middle), or doxycycline (dox) induction of AMOT-p130 and AMOTL1 shRNAs (right).(E) Proposed mechanism for AMOT-mediated regulation of YAP during neural differentiation. In NSCs, AMOT sequesters YAP at TJ, and a pool of nuclear YAP remains where it regulates self-renewal of NSCs. During initiation of neuronal commitment, TJs are downregulated and AMOT expression further increases. In soft microenvironments, F-actin polymerization is reduced and AMOT liberated. These events enable AMOT to sequester YAP in the cytoplasm where YAP undergoes proteasomal degradation. An absence of YAP from the nucleus lifts repression of neuronal differentiation.Scale bars, 50 μm. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.

From the initial data, we devised a model: a decrease in F-actin polymerization increases AMOT interaction with YAP and promotes YAP sequestration in the cytoplasm where YAP can be targeted for proteasomal degradation. We tested this model by targeting AMOT using conditional RNA interference. Because hPSCs express both AMOT and AMOTL1, and both contain F-actin and YAP binding sites, we employed inducible short hairpin RNAs (shRNAs) to downregulate both proteins. The expression of YAP target gene *CTGF* was used as a readout of YAP coactivator function and therefore indicative of nuclear YAP. Knockdown of either AMOT-p130 or AMOTL1 increased *CTGF* expression, indicating an increase in YAP\'s nuclear activity. Alternatively, knockdown of AMOT-p80 had no effect ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We also explored the link between F-actin polymerization and AMOT-YAP interaction. Our model indicates that in the absence of F-actin polymerization, AMOT enables YAP\'s sequestration in the cytosol. Accordingly, knockdown of AMOT should rescue YAP nuclear localization in cells treated with lat-A. Lat-A treatment afforded the expected decrease in YAP levels in the nucleus, and concomitant knockdown of AMOT-p130 and AMOTL1 rescued YAP nuclear localization and transcriptional control ([Figures 4](#fig4){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}B). In contrast, we observed no change upon knockdown of AMOT-p80, which cannot bind YAP ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These results indicate that AMOT regulates YAP localization in hPSCs in response to the status of the cell\'s cytoskeleton.

Modulating the levels of AMOT-p130 and AMOTL1 influences YAP localization in hPSCs. We hypothesized that altering the levels of these YAP interactors during neuronal differentiation would augment or inhibit differentiation, depending upon YAP\'s absence or presence in the nucleus, respectively. To this end, the forced expression of AMOT-p130 led to a decrease in YAP nuclear localization ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A) and promoted neuronal differentiation ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Since concomitant knockdown of AMOT-p130 and AMOTL1 increased YAP localization in the nucleus ([Figure S3](#mmc1){ref-type="supplementary-material"}A) and YAP promotes NSC self-renewal, we anticipated that AMOT knockdown during neuronal differentiation would augment the ratio of progenitor cells to differentiated cells. Indeed, following the induction of AMOT-p130 and AMOTL1 knockdown, we detected increased expression of progenitor genes *HES5* and *OLIG2* and decreased expression of the neuronal maturation gene *NEUROD1*. These results provide additional evidence that AMOT regulates YAP localization during neural differentiation ([Figure 4](#fig4){ref-type="fig"}E).

Discussion {#sec3}
==========

We previously reported that a decrease in F-actin polymerization effected either by culture on a pliable surface or by lat-A treatment induces neuronal differentiation of hPSCs and nuclear exclusion of YAP. These data link F-actin polymerization status to YAP subcellular localization, but the mechanism underlying the influence of the actin cytoskeleton on YAP localization was unclear. In the present study, we found that during neural differentiation AMOT protein levels increase as does AMOT binding to YAP and that these changes coincide with a decrease in YAP nuclear translocation. Blocking F-actin polymerization results in neuronal differentiation, and we also detect an increase in AMOT-YAP interactions. These results suggest that during neural differentiation AMOT acts as a link between the state of the actin cytoskeleton and YAP subcellular localization.

Our identification of AMOT as a regulator of YAP during neural differentiation was facilitated by performing AP-MS on endogenously tagged YAP. The approach is highly selective for YAP; in contrast, many antibodies used for immunoprecipitation also recognize the paralogous TAZ protein. Thus, the contribution of YAP versus TAZ to a given process can be difficult to discern. Exogenous expression of a tagged YAP construct can result in expression levels that differ from those of the endogenous protein and thus may not be representative of physiologically relevant interactions. Furthermore, YAP has eight alternatively spliced isoforms ([@bib15]), and picking just one isoform for expression can miss isoform-specific interactions, which have been documented for YAP ([@bib14]). Our system overcomes these challenges by tagging the endogenous protein, including all of its isoforms, and capturing it using magnetic beads conjugated to a highly specific antibody against the FLAG tag ([@bib6]). Finally, compared with transformed cell lines ([@bib8], [@bib19], [@bib33]), there are advantages to investigating YAP interactions in a cell line such as the one we utilize, which is non-transformed, diploid, and clonal.

AMOT has previously been shown to regulate YAP in other contexts. In epithelial and endothelial cells, AMOT, with its paralogs AMOTL1 and AMOTL2, localizes to TJs and regulates apical-basal polarity ([@bib24]). All three AMOT proteins, except for AMOT-p80, contain PPXY motifs that can bind to the WW domains of YAP ([@bib39]). These AMOT proteins include an F-actin binding domain that links the actin cytoskeleton to YAP subcellular localization in immortalized cell lines ([@bib22]). AMOT can also regulate YAP localization in endothelial cells in response to shear stress ([@bib28]), but a role for AMOT in sensing substrate elasticity was not known. We previously reported that hPSCs on pliant surfaces exhibit low levels of F-actin and exclude YAP from the nucleus, effects that can be mimicked with lat-A ([@bib26], [@bib27]). The observed increase in YAP-AMOT complexes following lat-A treatment suggests a novel role for AMOT in regulating YAP subcellular localization during hPSC mechanosensing, as well as in differentiation.

Although AMOT has not been previously implicated in neural differentiation, it is expressed in mammalian brain tissue ([@bib13]). Intriguingly, a recent study demonstrated that AMOT-p130 controls dendritic spine maturation in rat neurons ([@bib34]). Together with our observations, these findings indicate that an increase in AMOT-p130 expression during differentiation is vital for promoting both neuronal differentiation and maturation.

Our observations in mouse brain tissue suggest that AMOT regulates YAP during adult neurogenesis. These observations could extend to brain tumorigenesis, as AMOT has been linked to neural cancers. AMOT---the p130 isoform in particular---is upregulated in dormant versus fast-growing glioblastomas ([@bib3]). YAP also is upregulated in human brain cancers and promotes glioblastoma growth ([@bib29]). Our observations of AMOT-YAP interactions are consistent with a model in which concurrent upregulation of AMOT in dormant glioblastomas results in AMOT sequestration of YAP out of the nucleus, thereby inhibiting proliferation.

Several novel YAP interactors that we identified in undifferentiated cells point to a role for nuclear YAP in promoting self-renewal and in actively inhibiting differentiation. Specifically, during neural differentiation we detected fewer YAP complexes containing either the ARID3B or SALL4 transcription factors. ARID3B belongs to an AT-rich interaction domain family of DNA binding proteins and controls several genes responsible for pluripotency in hPSCs ([@bib21]). In cancer cells, *ARID3B* expression results in the downregulation of genes associated with neuron development ([@bib5]). SALL4 is a member of the *spalt*-like (SALL) C2H2-type zinc-finger transcription factors and was shown in ESCs to contribute to maintaining pluripotency by preventing activation of neural development genes ([@bib23]). In addition to its role as a coactivator, YAP can also function as a transcriptional corepressor ([@bib17]). Therefore, YAP\'s interaction with these transcription factors suggests a mechanism by which nuclear YAP represses neuronal differentiation in hPSCs.

We observed that increased AMOT levels during neural differentiation corresponded to an absence of YAP from the nucleus and a decrease in total YAP protein levels. YAP can be targeted for degradation in the cytoplasm by the ubiquitin-proteasome pathway ([@bib37]). In undifferentiated cells, YAP interacts with several components of the ubiquitin-proteasome system, and those interactions increase during differentiation. In cancer cells, AMOT-p130 can modulate cytoplasmic YAP stability by acting as a scaffold and recruiting a ubiquitin ligase that targets YAP for proteasomal degradation ([@bib1], [@bib2]). In hPSCs, proteasomal inhibition increased colocalization of YAP and AMOT in the cytoplasm. Thus, proteasome-mediated degradation of YAP may serve as an additional mode of regulation to prevent YAP from translocating to the nucleus and repressing the neuronal differentiation program.

In summary, we developed an engineered hPSC line and used it to identify that AMOT-YAP interactions can sequester YAP from the nucleus and thereby promote neural differentiation. We anticipate that this cell line will facilitate the elucidation of YAP interactions in response to other perturbagens in pluripotent cells and their differentiated progeny.

Experimental Procedures {#sec4}
=======================

Cell Culture and Differentiation {#sec4.1}
--------------------------------

H9 human ESC maintenance and neuronal differentiation were performed as described by [@bib35].

Immunoprecipitation and AP-MS {#sec4.2}
-----------------------------

Affinity purification of YAP-FLAG was performed using anti-FLAG M2 magnetic beads (Sigma-Aldrich). Analysis of protein samples by MS is described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Immunoblotting, Immunostaining, and qPCR {#sec4.3}
----------------------------------------

Methods for immunoblotting, immunostaining, and qPCR have been described ([@bib27]). Antibodies and primers are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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